Corporate Banner
Satellite Banner
Immunology
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Genetimes Technology Named as Nanoink’s New Distributor in China

Published: Thursday, January 24, 2013
Last Updated: Thursday, January 24, 2013
Bookmark and Share
Will distribute NanoInk's NLP 2000 System and DPN 5000 System.

NanoInk’s NanoFabrication Systems Division has announced that it has reached a non-exclusive agreement with Genetimes Technology Inc. to serve as its distributor in China.

Genetimes will distribute NanoInk's desktop nanofabrication equipment, including the NLP 2000 System and the DPN 5000 System, which have a wide range of applications ranging from nanoarray-based protein analysis to cell biology research.

Genetimes is a renowned life science equipment and consumable distributor and is dedicated to developing the nanobiotechnology market in China.

“With branch offices located in 12 cities, Genetimes has already established a strong relationship with NanoInk's target customers in the life science market. Its sales and technical teams have the in-depth knowledge required to understand life science applications, and they have proven expertise in selling technically-sophisticated equipment into that space. With these strengths, Genetimes is the ideal partner for driving sales of NanoInk's unique nanofabrication platforms for use in life science and bioengineering applications,” said Oliver Yeh, General Manager, NanoInk's NanoFabrication Systems Division, Asia-Pacific region.

Yeh continued, “We look forward to a close and successful long-term partnership with Genetimes as we expand our reach in China by promoting the unique capabilities and benefits of innovated NanoFabrication Systems from NanoInk.”

“We are delighted to be appointed as a distributor for NanoInk's products in China’s life science markets,” said Mr. Yuan Zhao, Senior Vice President, Marketing and International Operations at Genetimes Technology.

Mr. Zhao continued, “NanoInk's product lines are complementary to our current product portfolio and are attractive to cell biology markets. We look forward to working with the NanoInk team.”

NanoInk's NanoFabrication Systems Division brings sophisticated nanofabrication to the laboratory in an easy to use and affordable platform.

NanoInk's NLP 2000 System is a desktop nanolithography instrument that allows researchers to rapidly design and create custom engineered and functionalized surfaces by using Dip Pen Nanolithography® (DPN®) to transfer minute amounts of materials over a large, environmentally controlled work area.

With the ability to create custom patterns of nano- to microscale features in under an hour, the NLP 2000 System is valuable for protein and biomolecular patterning, microstructure and biosensor functionalization, cell biology and polymer printing applications.

The DPN 5000 System is a full-featured, dedicated instrument for versatile nanopatterning of a variety of materials with nanoscale accuracy and precision. With its user-friendly interface, it is possible to easily design complex patterns while also precisely controlling tip movements during the writing process.

The DPN 5000 System is the ideal platform for nanofabrication, nanomaterials and biomaterials applications that exhibit nanoscale printing, imaging and registration requirements.


Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,400+ scientific posters on ePosters
  • More than 3,700+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.


Scientific News
Sorting Through Cellular Statistics
Aaron Dinner, professor in chemistry, and his graduate student Herman Gudjonson are trying to read the manual of life, DNA, as part of the Dinner group’s research into bioinformatics—the application of statistics to biological research.
Women’s Immune System Genes Operate Differently from Men’s
A new technology reveals that immune system genes switch on and off differently in women and men, and the source of that variation is not primarily in the DNA.
Experimental MERS Vaccine Shows Promise in Animal Studies
A two-step regimen of experimental vaccines against Middle East respiratory syndrome (MERS) prompted immune responses in mice and rhesus macaques, report National Institutes of Health scientists who designed the vaccines.
HIV Susceptibility Linked to Little-Understood Immune Cell Class
High levels of diversity among immune cells called natural killer cells may strongly predispose people to infection by HIV, and may be driven by prior viral exposures, according to a new study.
New Weapon in the Fight Against Blood Cancer
This strategy, which uses patients’ own immune cells, genetically engineered to target tumors, has shown significant success against multiple myeloma, a cancer of the plasma cells that is largely incurable.
Scientists Create CRISPR/Cas9 Knock-In Mutations in Human T Cells
In a project spearheaded by investigators at UC San Francisco, scientists have devised a new strategy to precisely modify human T cells using the genome-editing system known as CRISPR/Cas9.
Researchers Develop Vaccine that Protects Primates Against Ebola
A collaborative team from The University of Texas Medical Branch at Galveston and the National Institutes of Health have developed an inhalable vaccine that protects primates against Ebola.
Universal Flu Vaccine in the Works
A new study has demonstrated a potential strategy for developing a flu vaccine with potent, broad protection.
Immunotherapy Shows Promise for Myeloma
A strategy, which uses patients’ own immune cells, genetically engineered to target tumors, has shown significant success against multiple myeloma, a cancer of the plasma cells that is largely incurable.
Immune System 'On Switch' Breakthrough Could Lead to Targeted Drugs
A crucial 'on switch' that boosts the body's defenses against infections has been successfully identified in new scientific research.
SELECTBIO

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,400+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,700+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FREE!